Medicines and leaflets
Results for the medicine trastuzumab
16 results
-
-
HERCEPTIN 150mg powder for concentrate for solution for infusion EGIS ORIGINAL MEDICINE
-
HERZUMA 150mg powder for concentrate for solution for infusion CELLTRION
-
HERZUMA 420mg powder for concentrate for solution for infusion CELLTRION
-
KADCYLA 100mg powder for concentrate for solution for infusion EGIS ORIGINAL MEDICINE
-
KADCYLA 160mg powder for concentrate for solution for infusion EGIS ORIGINAL MEDICINE
-
KANJINTI 150mg powder for concentrate for solution for infusion AMGEN
-
KANJINTI 420mg powder for concentrate for solution for infusion AMGEN
-
OGIVRI 150mg powder for concentrate for solution for infusion BIOSIMILAR COLLABORA
-
OGIVRI 420mg powder for concentrate for solution for infusion BIOSIMILAR COLLABORA
-
ONTRUZANT 150mg powder for concentrate for solution for infusion SAMSUNG BIOEPIS
-
TRAZIMERA 150mg powder for concentrate for solution for infusion PFIZER
-
TRAZIMERA 420mg powder for concentrate for solution for infusion PFIZER
-
ZERCEPAC 150mg powder for concentrate for solution for infusion ACCORD
-
ZERCEPAC 420mg powder for concentrate for solution for infusion ACCORD
-
ZERCEPAC 60mg powder for concentrate for solution for infusion ACCORD
Results for the substance trastuzumab
-
pertuzumab + trastuzumab
L01XY02 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Combinations of antineoplastic agents
-
trastuzumab
L01FD01 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors
-
trastuzumab deruxtecan
L01FD01 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors
-
trastuzumab emtansine
L01FD01 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors